0001607062-18-000339.txt : 20181015
0001607062-18-000339.hdr.sgml : 20181015
20181015161254
ACCESSION NUMBER: 0001607062-18-000339
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171121
FILED AS OF DATE: 20181015
DATE AS OF CHANGE: 20181015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Centofanti Kevin
CENTRAL INDEX KEY: 0001755795
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 181122350
MAIL ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 416-364-2551
MAIL ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
3
1
ownership.xml
X0206
3
2017-11-21
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001755795
Centofanti Kevin
10102 USA TODAY WAY
MIRAMAR
FL
33025
1
0
0
0
No securities are beneficially owned
0
D
/s/ Gary A. Miller as Attorney-in-Fact
2018-10-15